Fort Myers-based NeoGenomics Inc. reported revenue of $18.2 million for the first quarter. The company, a leading provider of genetic testing for cancer, saw its test volume grow 21 percent in the quarter, helping to drive a 16.1 percent year-over-year revenue increase.